What amount sold does Sun Diagnostics, LLC report in Form D filings?

The latest linked filings report $50K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Sun Diagnostics, LLC's most recent SEC filing?

Sun Diagnostics, LLC's most recent Form D filing was on 2014-01-28.

How many investors does Sun Diagnostics, LLC have?

The most recent Form D filing lists 1 investor(s).

What type of securities does Sun Diagnostics, LLC offer?

Sun Diagnostics, LLC's SEC Form D filings indicate equity offerings.

Sun Diagnostics, LLC

CIK: 0001598365·Biotechnology·NEW GLOUCESTER, ME·Limited Liability Company·Founded 2012

Reported Sold

$50,000

Total Filings

Identified Offerings

Last Filed

Jan 28, 2014

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jan 28, 2014Form D — New notice

Reported sold: $50,000 · Target: $300,000

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$50,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

John Contois

Related Person

Appears on 1 filing

Kwok Yeung

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 28, 2014	New	$300,000	$50,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

ARC Medical Inc.

Biotechnology

Offering target: $167,388

Filed Oct 9, 2026